FDA·Medicines·July 29, 2026

Bionpharma recalls Divalproex Sodium 500 mg delayed-release tablets over foreign tablets or capsules found in bottles

The notice says the 500-tablet bottles of Divalproex Sodium Delayed-Release Tablets, 500 mg, may contain foreign tablets or capsules, meaning pills that do not belong in the bottle.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Hazard
Presence of Foreign Tablets/Capsules
Units
N/A
Where sold
US Nationwide.
FDA classification
Class II · Ongoing
Classified by FDA
August 6, 2026
Recall started
June 26, 2026
FDA enforcement report
July 29, 2026
Identifiers
  • Codes: Lot# 704C003, Exp. 12/31/2028
  • FDA recall number: D-0742-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Reason for recall
Presence of Foreign Tablets/Capsules
Classification
Class II (Ongoing)
Distribution
US Nationwide.
Quantity
N/A

Related recalls